Healthcare AI Exits Pilot Phase, Enters Production Deployment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
BofA Securities on Doximity Inc (DOCS): 'No shift from DTC, but HCP growth is accelerating'
December 16, 2025 6:00 AM ESTBofA Securities analyst Allen Lutz reiterated a Buy rating and $82.00 price target on Doximity Inc (NYSE: DOCS).
The analyst comments "Yesterday, we hosted a conference call on pharma ad budgets with two industry executives, Andrew McLean, and Stuart Klein (bios below).... More
